Immunoglobulins, Normal Human, for Extravascular Adm. shortage in Austria

Is there an Immunoglobulins, Normal Human, for Extravascular Adm. shortage in Austria?

Yes. As of 2 Nov 2026, 7 Immunoglobulins, Normal Human, for Extravascular Adm. products are reported short in Austria, the first since 25 Nov 2020. No return date has been given. Main reason: active ingredient shortage.

Also short in Italy, Czechia. All countries.

Affected products in Austria

Country	Product	Company	Since	Expected back	Reason
AT	Cuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 1 x 10 ml	Baxalta Innovations GmbH	25 Nov 2020	not given	Active ingredient shortage Verknappung des Wirkstoffes
AT	Cuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 1 x 20 ml	Baxalta Innovations GmbH	25 Nov 2020	not given	Active ingredient shortage Verknappung des Wirkstoffes
AT	Cuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 1 x 40 ml	Baxalta Innovations GmbH	25 Nov 2020	not given	Active ingredient shortage Verknappung des Wirkstoffes
AT	Cuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 10 x 10 ml	Baxalta Innovations GmbH	25 Nov 2020	not given	Active ingredient shortage Verknappung des Wirkstoffes
AT	Cuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 10 x 20 ml	Baxalta Innovations GmbH	25 Nov 2020	not given	Active ingredient shortage Verknappung des Wirkstoffes
AT	Cuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 30 x 10 ml	Baxalta Innovations GmbH	25 Nov 2020	not given	Active ingredient shortage Verknappung des Wirkstoffes
AT	Cuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 5 x 40 ml	Baxalta Innovations GmbH	25 Nov 2020	not given	Active ingredient shortage Verknappung des Wirkstoffes

Source

BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).